Multiple credible sources tell On The Pen that Novo Nordisk is preparing to launch a multi-dose Wegovy FlexTouch pen in the United States in the coming weeks, and FDA records show the device is already approved.

For years, American Wegovy patients have been using a remarkably inflexible delivery system for a disease that is anything but predictable. One …